By Robin Foster HealthDay ReporterTUESDAY, Oct. 15, 2024 (HealthDay News) — Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the U.S. Food and Drug Administration revisits its Oct. 2 decision to remove the medicine from a national drug shortage list.What prompted the FDA to reconsider its …

Approval is for prophylactic treatment and targets protein in the blood clotting process

At one year after treatment, collagenase was not noninferior to limited fasciectomy with respect to the score on the PEM

By Ernie Mundell HealthDay ReporterFRIDAY, Oct. 11, 2024 (HealthDay News) — Facing a nationwide shortage of vital IV fluids after Hurricane Helene knocked out a North Carolina production plant, officials heaved a sigh of relief at the news that a second plant in Daytona Beach, Fla., was spared by Hurricane …

EBP device in nonemergent cardiac surgery linked to lower rate of CSA-acute kidney injury in patients after cardiopulmonary bypass

Intervention involves daily multidisciplinary rounds and monthly audit and feedback by board-certified remote intensivists

No major functional disabilities observed at month 24; 81 percent of patients had no major functional disabilities at median of six years

Extreme events are associated with increased risk for all-cause, cardiovascular, and respiratory mortality

74 percent of patients had the same changes from pretreatment to posttreatment with T1 + contrast and MRI-linac lesions

By Dennis Thompson and Lori Saxena HealthDay ReportersMONDAY, Oct. 7, 2024 (HealthDay News) — A pair of American scientists has been honored with the 2024 Nobel Prize in Medicine for their role in the groundbreaking discovery of microRNA—tiny genetic molecules that play a crucial role in gene regulation and how …